RZ-g001BE

N/A

Report date: 2025/05/16 15:01:19
First In Class

Base Information

Drug NameRZ-g001BE
Drug Alias NameRZ-g001BE
ClassificationCell and gene therapy > Gene therapy > Gene editing > Base editing
Mechanisms of ActionSodium channel protein type V alpha subunit modulators
TargetsSodium channel protein type V alpha subunit
Therapy Area/IndicationsLong QT Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Rongze Biological Technology Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Rongze Biological Technology Group Co Ltd
Inactive CompaniesN/A
Active IndicationsLong QT Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A